Literature DB >> 11177731

Preparation of the HIV-infected Traveler to the Tropics.

Christopher L. Karp1.   

Abstract

Pre-travel advice and planning can help the HIV-infected traveler minimize the unavoidable risks of tropical travel. Issues to cover: the diagnosis, staging, and stabilization of HIV infection and its sequelae; adequacy of the supply of medications currently used; optimal sources of medical care in planned destinations; potential HIV-related legal restrictions on travel; special risks associated with the medical geography of the traveler's route and planned activities; the need to avoid food-, water-, and vector-borne diseases; any appropriate vaccination, chemoprophylaxis, and antimicrobial agents; and arrangement for adequate medical follow-up upon the traveler's return.

Entities:  

Year:  2001        PMID: 11177731     DOI: 10.1007/s11908-001-0059-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  63 in total

Review 1.  Antiretroviral treatment and travel to developing countries.

Authors:  R Colebunders; J Nachega; A Van Gompel
Journal:  J Travel Med       Date:  1999-03       Impact factor: 8.490

2.  Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.

Authors:  T S Sibailly; S Z Wiktor; T F Tsai; B C Cropp; E R Ekpini; G Adjorlolo-Johnson; E Gnaore; K M DeCock; A E Greenberg
Journal:  Pediatr Infect Dis J       Date:  1997-12       Impact factor: 2.129

3.  The sexual behaviour of international travellers at two Glasgow GUM clinics. Glasgow genitourinary medicine.

Authors:  S Carter; K Horn; G Hart; M Dunbar; A Scoular; S MacIntyre
Journal:  Int J STD AIDS       Date:  1997-05       Impact factor: 1.359

Review 4.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 5.  Epidemiology of travelers' diarrhea and relative importance of various pathogens.

Authors:  R E Black
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

6.  Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir.

Authors:  L L von Moltke; D J Greenblatt; J M Grassi; B W Granda; S X Duan; S M Fogelman; J P Daily; J S Harmatz; R I Shader
Journal:  J Clin Pharmacol       Date:  1998-02       Impact factor: 3.126

7.  Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases.

Authors:  E Rosenthal; P Marty; Y le Fichoux; J P Cassuto
Journal:  Ann Trop Med Parasitol       Date:  2000-01

8.  Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.

Authors:  J K Coller; A A Somogyi; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

9.  In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.

Authors:  D J Birkett; D Rees; T Andersson; F J Gonzalez; J O Miners; M E Veronese
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

10.  Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.

Authors:  A Adedoyin; R F Frye; K Mauro; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.